Why your prescription purpose doesnt disqualify you: The injury is the same whether you took the drug for diabetes or weight loss The warnings were inadequate for both approved uses The mechanism is identical regardless of indication The failure to warn affected all patients, not just one category In fact, diabetes patients may have stronger arguments: You needed the medication for a serious health condition You had fewer alternatives available The risk-benefit calculation was different You were a captive market with less choice Your claim will focus on: Whether you were adequately informed of gastroparesis risk Whether the severity and potential permanence were disclosed Whether you would have chosen differently if properly warned The damages you suffered as a result Q: What if I took multiple GLP-1 drugs over time
However, patient's expectations, treatment satisfaction and the outcomes achieved are also relevant and should be considered [9, 20]
Cryer PE, Davis SN, Shamoon H
Possible Side Effects Observed in Research & Clinical Settings Melanotan II (MT-II) is generally regarded in research settings as a well-tolerated melanocortin receptor agonist peptide with a pigmentation-related and neuroendocrine research profile
Deng M, Guerrero-Juarez CF, Sheng X, Xu J, Wu X, Yao K, Li M, Yang X, Li G, Xiao J, et al
The glutathiones molecule is too large to get through the intestinal wall intact
